Your browser doesn't support javascript.
loading
Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia.
Lin, Willie; Teng, Sen-Wen; Lin, Tzu-Yi; Lovel, Ronald; Sung, Hsin-Yu; Chang, Wen-Ying; Wu, Tang Bo-Chung; Chen, Hsuan-Yu; Wang, Le-Ming; Shaw, Steven W.
Afiliación
  • Lin W; Meridigen Biotech Co., Ltd., Taipei 114, Taiwan.
  • Teng SW; Department of Obstetrics and Gynecology, Cardinal Tien Hospital, New Taipei 231, Taiwan.
  • Lin TY; School of Medicine, Fu-Jen Catholic University, New Taipei 242, Taiwan.
  • Lovel R; College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
  • Sung HY; Meribank Biotech Co., Ltd., Taipei 114, Taiwan.
  • Chang WY; Meribank Biotech Co., Ltd., Taipei 114, Taiwan.
  • Wu TB; Meribank Biotech Co., Ltd., Taipei 114, Taiwan.
  • Chen HY; Meridigen Biotech Co., Ltd., Taipei 114, Taiwan.
  • Wang LM; Meribank Biotech Co., Ltd., Taipei 114, Taiwan.
  • Shaw SW; Department of Obstetrics and Gynecology, Wan Fang Hospital, Taipei 116, Taiwan.
Diagnostics (Basel) ; 12(7)2022 Jun 23.
Article en En | MEDLINE | ID: mdl-35885439
ABSTRACT
We aim to establish a prediction model for pregnancy outcomes through a combinatorial analysis of circulating biomarkers and maternal characteristics to effectively identify pregnant women with higher risks of preeclampsia in the first and third trimesters within the Asian population. A total of two hundred and twelve pregnant women were screened for preeclampsia through a multicenter study conducted in four recruiting centers in Taiwan from 2017 to 2020. In addition, serum levels of sFlt-1/PlGF ratio, miR-181a, miR-210 and miR-223 were measured and transformed into multiples of the median. We thus further developed statistically validated algorithmic models by designing combinations of different maternal characteristics and biomarker levels. Through the performance of the training cohort (0.848 AUC, 0.73−0.96 95% CI, 80% sensitivity, 85% specificity, p < 0.001) and the validation cohort (0.852 AUC, 0.74−0.98 95% CI, 75% sensitivity, 87% specificity, p < 0.001) from one hundred and fifty-two women with a combination of miR-210, miR-181a and BMI, we established a preeclampsia prediction model for the first trimester. We successfully identified pregnant women with higher risks of preeclampsia in the first and third trimesters in the Asian population using the established prediction models that utilized combinatorial analysis of circulating biomarkers and maternal characteristics.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Taiwán